STILL SEEKING OUTCOMES AFTER 6TH STOMA APPLIANCE SCHEME SCHEDULE REVIEW:
LOWER QUALITY OF LIFE AND OTHER HEALTH IMPACTS EXPERIENCED BY OSTOMATES
Matt Dalton
Chair, Stoma Industry Association
SEGMENT RELEASE
Filmed in Sydney, New South Wales | December 2024
A stoma is a surgically created opening in the abdomen to remove body waste, such as faeces and urine. Many conditions can require a stoma, including colorectal cancer, inflammatory bowel disease (IBD), Crohn’s disease and ulcerative colitis, bladder cancer, injury trauma, and congenital defects.
50,000 Australians have undergone the trauma and challenge of having a stoma inserted. Whilst the Australian Government invests in the appliances and products they need through the Stoma Appliance Scheme (SAS), this list is dated and doesn’t include as many of the products available in other countries. A new report commissioned by the Stoma Industry Association (SIA) shows Australia lagging countries such as the United Kingdom, Canada and Spain in supporting ostomates (people with a stoma).
The report found that the Quality of Life (QoL) for Australian ostomates is lower than other developed nations and the general community. The reason for this includes:
- Australia reimburses fewer products on the Stoma Appliance Scheme (SAS). The UK provides 60 per cent more, for example.
- Australian spending as a percentage of GDP is five times smaller than Canada, and three times smaller than the UK.
- There are fewer specialist nurses to support the patient population. According to the Australian Association of Stomal Therapy Nurses, “A Stomal Therapy Nurse (STN) specialises in the management of patients with faecal and urinary diversions. In addition, the STN is an expert in the management of difficult and draining wounds, fistulae, gastrostomies, acute and chronic wounds and associated skin care. In short, STNs can assist with advice and management of any stoma and wound issue, and may also provide continence advice.”
The report also details the daily challenges of Australian ostomates:
- 1 in 5 stoma patients isolate themselves from others
- 65 per cent of patients say their ability to work is negatively impacted
- 3 in 5 patients experience a reduction in intimacy
Stoma appliances and supporting products are subsidised by the Commonwealth funded scheme.
There have been five reviews of the SAS, none of which have been released. The current (sixth) review released earlier this year by the Australian Government.
Australian Health Journal spoke with the Stoma Industry Association Chair, Matt Dalton about the same access to products needed by 50,000 Australian ostomates and the quality of life as patients overseas.
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
Sharing the same goals in value-based procurement
Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.
